Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo

Background: Transcatheter aortic valve implantation (TAVI) is an effective and safe option for low, medium and high-risk patients with severe aortic stenosis (SAS). Aim: To analyze the clinical results and long-term survival of TAVI in our center. Material and Methods: Prospective analysis of 53...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pérez,Luis, Venegas,Reinaldo, Ibieta,Guillermo, Lecannelier,Eduardo, Stockins,Aleck, Sanhueza,Eugenio, Fasce,Fabrizio, González,Alicex, Sáez,Jatún, Sandoval,Constanza, Segall,Virginia, Robles,Isabel
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2021
Materias:	Aortic Valve Stenosis Heart Valve Disease Transcatheter Aortic Valve Implantation
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000400514
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872021000400514
record_format	dspace
spelling	oai:scielo:S0034-988720210004005142021-08-26Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneoPérez,LuisVenegas,ReinaldoIbieta,GuillermoLecannelier,EduardoStockins,AleckSanhueza,EugenioFasce,FabrizioGonzález,AlicexSáez,JatúnSandoval,ConstanzaSegall,VirginiaRobles,Isabel Aortic Valve Stenosis Heart Valve Disease Transcatheter Aortic Valve Implantation Background: Transcatheter aortic valve implantation (TAVI) is an effective and safe option for low, medium and high-risk patients with severe aortic stenosis (SAS). Aim: To analyze the clinical results and long-term survival of TAVI in our center. Material and Methods: Prospective analysis of 53 patients aged 73 ± 10 years with a Society of Thoracic Surgeons (STS) score of 7.3 ± 3.9%. Results: In 96% a transfemoral access was used and, in most patients, ProGlides™ as vascular closure device was used. General anesthesia and conscious sedation were used in 79 and 21% of cases, respectively. Fifty-three valves were implanted, 42 self-expandable (SEV) and 11 balloon-expandable (Edwards Sapiens). The implant was successful in 49 patients (92,4%). The transaortic gradient after TAVI was almost zero mmHg in all patients and one had a severe aortic regurgitation. Permanent pacemakers were needed in 17% of patients. Two patients had a pericardial effusion, and one had a major vascular complication. No strokes were recorded, and 30-day mortality was 3.7%. At long-term follow up (23.4 ± 21.6 months) the global survival was 85% and the rate of cardiovascular mortality was 5.9%. Conclusions: In this series of intermediate to high-risk patients, TAVI was associated with an excellent early and long-term survival.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.4 20212021-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000400514es10.4067/s0034-98872021000400514
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Aortic Valve Stenosis Heart Valve Disease Transcatheter Aortic Valve Implantation
spellingShingle	Aortic Valve Stenosis Heart Valve Disease Transcatheter Aortic Valve Implantation Pérez,Luis Venegas,Reinaldo Ibieta,Guillermo Lecannelier,Eduardo Stockins,Aleck Sanhueza,Eugenio Fasce,Fabrizio González,Alicex Sáez,Jatún Sandoval,Constanza Segall,Virginia Robles,Isabel Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
description	Background: Transcatheter aortic valve implantation (TAVI) is an effective and safe option for low, medium and high-risk patients with severe aortic stenosis (SAS). Aim: To analyze the clinical results and long-term survival of TAVI in our center. Material and Methods: Prospective analysis of 53 patients aged 73 ± 10 years with a Society of Thoracic Surgeons (STS) score of 7.3 ± 3.9%. Results: In 96% a transfemoral access was used and, in most patients, ProGlides™ as vascular closure device was used. General anesthesia and conscious sedation were used in 79 and 21% of cases, respectively. Fifty-three valves were implanted, 42 self-expandable (SEV) and 11 balloon-expandable (Edwards Sapiens). The implant was successful in 49 patients (92,4%). The transaortic gradient after TAVI was almost zero mmHg in all patients and one had a severe aortic regurgitation. Permanent pacemakers were needed in 17% of patients. Two patients had a pericardial effusion, and one had a major vascular complication. No strokes were recorded, and 30-day mortality was 3.7%. At long-term follow up (23.4 ± 21.6 months) the global survival was 85% and the rate of cardiovascular mortality was 5.9%. Conclusions: In this series of intermediate to high-risk patients, TAVI was associated with an excellent early and long-term survival.
author	Pérez,Luis Venegas,Reinaldo Ibieta,Guillermo Lecannelier,Eduardo Stockins,Aleck Sanhueza,Eugenio Fasce,Fabrizio González,Alicex Sáez,Jatún Sandoval,Constanza Segall,Virginia Robles,Isabel
author_facet	Pérez,Luis Venegas,Reinaldo Ibieta,Guillermo Lecannelier,Eduardo Stockins,Aleck Sanhueza,Eugenio Fasce,Fabrizio González,Alicex Sáez,Jatún Sandoval,Constanza Segall,Virginia Robles,Isabel
author_sort	Pérez,Luis
title	Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
title_short	Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
title_full	Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
title_fullStr	Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
title_full_unstemmed	Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
title_sort	sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo
publisher	Sociedad Médica de Santiago
publishDate	2021
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000400514
work_keys_str_mv	AT perezluis sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT venegasreinaldo sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT ibietaguillermo sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT lecanneliereduardo sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT stockinsaleck sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT sanhuezaeugenio sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT fascefabrizio sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT gonzalezalicex sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT saezjatun sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT sandovalconstanza sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT segallvirginia sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo AT roblesisabel sobrevidaalejadadelospacientesconestenosisaorticaseveratratadosconimplantevalvularpercutaneo
_version_	1718437195631558657

Sobrevida alejada de los pacientes con estenosis aórtica severa tratados con implante valvular percutáneo

Ejemplares similares